Kelyniam Global, Inc. (KLYG)
USD 0.22
(22.22%)
USD 0.22
(22.22%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.67 Million USD | -11.44% |
| 2022 | 3.01 Million USD | 13.25% |
| 2021 | 2.66 Million USD | 6.06% |
| 2020 | 2.51 Million USD | 15.07% |
| 2019 | 2.18 Million USD | 2.8% |
| 2018 | 2.12 Million USD | 14.91% |
| 2017 | 1.84 Million USD | 21.1% |
| 2016 | 1.52 Million USD | 0.43% |
| 2015 | 1.51 Million USD | -13.09% |
| 2014 | 1.74 Million USD | -5.87% |
| 2013 | 1.85 Million USD | 0.0% |
| 2007 | 46.56 Thousand USD | -32.76% |
| 2006 | 69.25 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 957.44 Thousand USD | 2.87% |
| 2024 Q2 | 751.79 Thousand USD | -21.48% |
| 2023 Q1 | 596.45 Thousand USD | -27.54% |
| 2023 FY | 2.67 Million USD | -11.44% |
| 2023 Q2 | 550.59 Thousand USD | -7.69% |
| 2023 Q3 | 594.54 Thousand USD | 7.98% |
| 2023 Q4 | 930.77 Thousand USD | 56.55% |
| 2022 Q4 | 823.16 Thousand USD | 13.53% |
| 2022 Q2 | 815.86 Thousand USD | 24.85% |
| 2022 Q1 | 653.48 Thousand USD | -8.11% |
| 2022 FY | 3.01 Million USD | 13.25% |
| 2022 Q3 | 725.08 Thousand USD | -11.13% |
| 2021 FY | 2.66 Million USD | 6.06% |
| 2021 Q2 | 559.7 Thousand USD | -15.75% |
| 2021 Q3 | 729.2 Thousand USD | 30.28% |
| 2021 Q1 | 664.35 Thousand USD | 22.74% |
| 2021 Q4 | 711.16 Thousand USD | -2.47% |
| 2020 Q1 | 585.78 Thousand USD | -22.16% |
| 2020 Q4 | 541.28 Thousand USD | -24.25% |
| 2020 FY | 2.51 Million USD | 15.07% |
| 2020 Q3 | 714.57 Thousand USD | 6.58% |
| 2020 Q2 | 670.44 Thousand USD | 14.45% |
| 2019 Q2 | 394.69 Thousand USD | -26.53% |
| 2019 FY | 2.18 Million USD | 2.8% |
| 2019 Q4 | 752.52 Thousand USD | 50.9% |
| 2019 Q1 | 537.2 Thousand USD | 0.0% |
| 2019 Q3 | 498.7 Thousand USD | 26.35% |
| 2018 FY | 2.12 Million USD | 14.91% |
| 2017 FY | 1.84 Million USD | 21.1% |
| 2016 FY | 1.52 Million USD | 0.43% |
| 2015 FY | 1.51 Million USD | -13.09% |
| 2014 Q1 | 540.28 Thousand USD | 0.0% |
| 2014 FY | 1.74 Million USD | -5.87% |
| 2014 Q3 | 455.4 Thousand USD | 0.0% |
| 2014 Q4 | 356.21 Thousand USD | -21.78% |
| 2013 Q2 | 593.35 Thousand USD | 35.65% |
| 2013 Q1 | 437.41 Thousand USD | 0.0% |
| 2013 FY | 1.85 Million USD | 0.0% |
| 2008 Q1 | 5450.00 USD | -16.15% |
| 2007 Q1 | 24.45 Thousand USD | 0.0% |
| 2007 Q4 | 6500.00 USD | 4.08% |
| 2007 Q3 | 6245.00 USD | -33.32% |
| 2007 FY | 46.56 Thousand USD | -32.76% |
| 2007 Q2 | 9366.00 USD | -61.7% |
| 2006 FY | 69.25 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -273.909% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | -199.95% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 5.148% |
| Avitar, Inc. | 3.1 Million USD | 13.968% |
| AVITA Medical, Inc. | 50.56 Million USD | 94.715% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.66% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -2985.506% |
| QHSLab, Inc. | 1.4 Million USD | -89.664% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.66% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 94.921% |
| Escalon Medical Corp. | 11.98 Million USD | 77.696% |
| Aurora Spine Corporation | 14.52 Million USD | 81.596% |
| BrainsWay Ltd. | 31.78 Million USD | 91.592% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -938.216% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 96.096% |
| Vivos Inc. | 19.5 Thousand USD | -13604.395% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.719% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -1211.792% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -3063.152% |
| Nanomix Corporation | 15.45 Thousand USD | -17196.809% |
| Theraclion SA | 1.82 Million USD | -46.654% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -303.954% |
| Positron Corporation | 734.66 Thousand USD | -263.751% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -98.127% |
| Lombard Medical, Inc. | 12.16 Million USD | 78.04% |
| ALR Technologies Inc. | 7468.00 USD | -35684.106% |
| Stratec SE | 289.14 Million USD | 99.076% |
| Vycor Medical, Inc. | 1.46 Million USD | -82.962% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -562.24% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 86.899% |
| VMS Rehab Systems, Inc. | 71.70 USD | -3727036.681% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -2626.895% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -270.812% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 6.077% |
| Urologix, Inc. | 14.23 Million USD | 81.227% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 19.088% |
| SS Innovations International, Inc. | 5.87 Million USD | 54.55% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -6551.791% |
| Smith & Nephew plc | 5.68 Billion USD | 99.953% |
| NIOX Group Plc | 46.84 Million USD | 94.295% |
| Fuse Medical, Inc. | 16.11 Million USD | 83.417% |
| Broncus Holding Corporation | 10.25 Million USD | 73.941% |
| Brain Scientific Inc. | 214.56 Thousand USD | -1145.482% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -35.12% |
| Health Logic Interactive Inc. | - USD | -Infinity% |